Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The technological edge.

Justin Furness1

  • 1justin.furness@quotec.co.uk

Medical Device Technology
|June 18, 2002
PubMed
Summary

New diagnostic tools for rheumatoid arthritis and kidney disease are now available. These advancements utilize novel spin-trapping assays and bench-top instrumentation for improved monitoring and diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The technological edge.

Medical device technology·2002
Same author

The technological edge.

Medical device technology·2002
Same author

The technological edge.

Medical device technology·2002
See all related articles

Area of Science:

  • Biochemistry
  • Medical Diagnostics
  • Analytical Chemistry

Background:

  • Rheumatoid arthritis (RA) and renal disease pose significant health challenges.
  • Accurate diagnosis and monitoring are crucial for effective management of these conditions.
  • Current diagnostic methods may have limitations in sensitivity or accessibility.

Purpose of the Study:

  • To introduce novel spin-trapping assays for disease diagnosis.
  • To present new bench-top instrumentation for clinical applications.
  • To enable improved monitoring of conditions associated with RA and renal disease.

Main Methods:

  • Development of advanced spin-trapping techniques.
  • Implementation of user-friendly bench-top instrumentation.
  • Validation of assays for detecting disease-specific biomarkers.

Main Results:

  • Demonstrated feasibility of novel assays for diagnosing RA and renal disease.
  • Successful application of bench-top instrumentation in preliminary studies.
  • Potential for enhanced monitoring of disease progression and treatment response.

Conclusions:

  • New instrumentation and assays offer a promising approach for diagnosing and monitoring RA and renal disease.
  • These advancements could lead to earlier and more accurate patient management.
  • Further clinical validation is warranted to fully realize the potential of these tools.

Related Experiment Videos